+5

Galderma neuromodulators portfolio

Xiaoming LIN

+5

Aesthetic toxins: Allergan's pipeline & future

Elisabeth LEE

+5

Aesthetic toxins: Sinclair's pipeline & future

Ryan IRVINE

+5

Maximizing patient lifetime value for enhanced retention and revenue growth

Robin NTOH

+5

Motivating and retaining a rockstar staff

Jeanette POEHLER

+5

The patient will see you now

Marilyn CAPOTE

+5

Breaking up is hard to do

Leslie FLETCHER

+5

Demand forecasting for dermatology clinics

Anjali ANCY

+5

Trends in medical marketing for 2025: the role of social media in patient education

Dr. Irina STOYANOVA

+5

Medical tourism: a comprehensive guide to becoming a global leader

Iman MIR

+5

KPI, skills, expertise, and experience are not enough

Valerie MIGNON

+5

Exosomes: the reality of complications and regulations in the US and abroad

Dr. Jane YOO

+5

Exosomes: what is real in 2025?

Dr. Monika FIDA

+5

What's in the package? Decoding exosomes and directing therapies

Dr. Diane Irvine DUNCAN

+5

Exosomes: the last frontier of aesthetic medicine or a nonsense fashion?

Dr. Hernan PINTO